
Andreia Albuquerque
@aalbuquerqu_
Gastroenterologist MD PhD. Assistant Professor. AnaI HPV/anal cancer, IBD, Neurogastro, Endoscopy. GI Cancer prevention. @IPVSociety Board Member.
ID: 968953081860894723
http://andreiaalbuquerque.com/research 28-02-2018 20:56:31
420 Tweet
288 Followers
587 Following



Data from 830,000 women in the Swedish #HPV-based cervical screening program showed that the declines of HPV16/18 were considerably larger than #HPVvaccination coverage, suggesting herd immunity effects bit.ly/4hqKitm Journal of Infectious Diseases Joakim Dillner Karolinska Institutet #OpenAcess



Recent #NHANES study found an association between oral #microbiome diversity and oral #HPV infection on a population level, which could lead to a greater understanding of the natural history of oral HPV infection and disease progression. 👉bit.ly/4aZZUSa Xinyi (Cindy) Feng


Each month, hear from the energetic group of IPVS Country Ambassadors around the world. Meet Emmanuel Timmy Donkoh, IPVS Country Ambassador for Ghana 🇬🇭 who is leading impactful work in his country. #HPV #cervicalcancer ET Donkoh Screen-and-Treat Research Group Centre for Research in Applied Biology UENR


Philipp Münick & colleagues at Goethe University designed a protein that blocks #HPV E6 from degrading p53, restoring its tumor-suppressing function and highlighting a potential therapeutic strategy for HPV-related #cancers Access the paper 👉 bit.ly/3DcWYoU NatureStructMolBiol



Data from the CervicalScreen Norway showing that the risk of being #HPV-positive and having high-grade cytology among HPV-positives was lower in the second screening round compared to the first Read the paper 👉 bit.ly/3QTG6q9 International Journal of Cancer #cervicalcancer #cancerscreening


Today is Anal Cancer Awareness Day. Prevention starts with awareness. Join IPVS educational webinar on Controversies in Anal Cancer Screening on April 9. Register now 👉 bit.ly/427KKX9 #analcancer #onelessworry Andreia Albuquerque



Cervical Cancer treatment studies show no survival advantage of chemoradiotherapy over radiotherapy alone. These results support a more selective approach, reducing unnecessary toxicity for patients with intermediate-risk cervical cancer JAMA Oncology 👉 bit.ly/3YC63yO







